Serum IGFBP3 is a more effective predictor than IGF1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection

Author:            

Publisher: Spandidos Publications

ISSN: 1792-1074

Source: Oncology Letters, Vol.3, Iss.3, 2012-01, pp. : 704-712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content